ARMP — ARMATA PHARMACEUTICALS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ARMATA PHARMACEUTICALS INC (ARMP)
ARMATA PHARMACEUTICALS INC (ARMP) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $3M. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ARMP
How many top investors track ARMP
Only 2 tracked investors report this position.
ARMP Ownership Composition
How ARMATA PHARMACEUTICALS INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting ARMP
- Izzy EnglanderMar 31, 2026Millennium ManagementShares258KValue$2.6M% Portfolio0.00%
- Ken GriffinDec 31, 2025Citadel AdvisorsShares10.8KValue$67.7K% Portfolio0.00%
Recent activity
- $163.8KFeb 17, 2026
- $2.6MMay 15, 2026
Frequently asked questions
- How many institutional investors hold ARMP?
- 2 tracked institutional investors disclosed a position in ARMP (ARMATA PHARMACEUTICALS INC) in their most recent 13F filing.
- Who is the largest institutional holder of ARMP?
- Izzy Englander, Millennium Management, holds the largest disclosed position in ARMP, valued at $3M.
- Did institutional ownership of ARMP increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited ARMP.
- Where does this ARMP ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.